Cytogenetic features and its clinical implications in Japanese patients with multiple myeloma: retrospective analysis by Japan Myeloma Study Group

Cytogenetic features and its clinical implications in Japanese patients with multiple myeloma: retrospective analysis by Japan Myeloma Study Group - Retrospective analysis in cytogenetic features and its clinical implications in Japanese multiple myeloma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000001385

Enrollment

650

Registered

2008-09-22

Start date

2007-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Eligibility: 1)asymptomatic or symptomatic multiple myeloma 2)Japanese patients 3)diagnosed and initially treated in Japan Myeloma Study Group between January 1, 1997 and December 31, 2006. 4)Cytogenetic examination using either metaphase G-banding or interphase fluorescence in situ hybridization(FISH) at least once during clinical course

Exclusion criteria

Exclusion criteria: Exclusion criteria 1) monoclonal gammopathy of undetermined significance(MGUS) 2) extramedulary plasmacytoma 3) prior history of MGUS or extramedulary plasmacytoma

Design outcomes

Primary

Measure	Time frame
1.cytogenetic abnormalities and their prevalence 2.cytogenetic features and its clinical implications	—

Countries

Japan

Contacts

Public ContactIsamu Sugiura

Toyohashi Municipal Hospital Division of Hematology and Oncology

sugiura-isamu@toyohashi-mh.jp

Outcome results